Fibrostatin C is a prolyl hydroxylase inhibitor with oral activity that also inhibits collagen biosynthesis; it increases the number of cytoplasmic granules immunoreactive with collagen I or III antibodies and suppresses type I collagen secretion in Tenon's capsule fibroblasts; it shows potential for research into fibrotic responses following glaucoma filtration surgery.